Dexamethasone
Key facts
Active substance |
dexamethasone
|
Therapeutic area |
Ophthalmology
|
Decision number |
P/68/2008
|
PIP number |
Dexamethasone
|
Pharmaceutical form(s) |
Intravitreal implant in an applicator
|
Condition(s) / indication(s) |
Other retinal vascular occlusion
|
Route(s) of administration |
Intravitreal use
|
Contact for public enquiries |
Allergan Pharmaceuticals International Limited
E-mail: ml-eu_reg_affairs@allergan.com |
Decision type |
W: decision granting a waiver in all age groups for all conditions or indications
|